Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Xtant Medical Holdings Inc shares valued at $30,708,129 were sold by ORBIMED ADVISORS LLC on Apr 10 ’25. At $0.42 per share, ORBIMED ADVISORS LLC sold 73,114,592 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
As published in their initiating research note from BTIG Research on December 05, 2023, Xtant Medical Holdings Inc [XTNT] has been a Buy and the price target has been revised to $2. Analysts at Maxim Group resumed the stock at ‘”a Buy”‘ outlook in a report released in mid November. As of February 14, 2018, Maxim Group has reiterated its “Buy” rating for XTNT.
Analyzing XTNT Stock Performance
During the last five days, there has been a surge of approximately 18.16%. Over the course of the year, Xtant Medical Holdings Inc shares have jumped approximately 1.35%. Shares of the company reached a 52-week high of $0.6700 on 02/04/25 and a 52-week low of $0.3401 on 04/10/25. A 50-day SMA is recorded $0.4933, while a 200-day SMA reached $0.5490.
Support And Resistance Levels for Xtant Medical Holdings Inc (XTNT)
According to the 24-hour chart, there is a support level at 0.4117, which, if violated, would cause prices to drop to 0.3745. In the upper region, resistance lies at 0.4676. The next price resistance is at 0.4863. RSI (Relative Strength Index) is 49.99 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0177, which suggests the price will decrease in the coming days. Percent R is at 35.79%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
